Chinese biotech startup Shanghai Junshi Biosciences Co Ltd soared more than 22 per cent in its Hong Kong debut on Monday after raising $394 million in its IPO, a rare strong showing by a biotech company in the Asian financial hub.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in